Skip to main content
NCBI home page
Springer logoLink to Springer
. 2022 Nov 9;45(6):1253. doi: 10.1007/s13402-022-00735-z

Correction to: ABCA6 affects the malignancy of Ewing sarcoma cells via cholesterol-guided inhibition of the IGF1R/AKT/MDM2 axis

Michela Pasello 1,✉, Anna Maria Giudice 1,2,3, Camilla Cristalli 1, Maria Cristina Manara 1, Caterina Mancarella 1, Alessandro Parra 1, Massimo Serra 1, Giovanna Magagnoli 4, Florencia Cidre-Aranaz 5,6, Thomas G P Grünewald 5,6,7, Carla Bini 8, Pier-Luigi Lollini 3, Alessandra Longhi 9, Davide Maria Donati 10,11, Katia Scotlandi 1,✉
PMCID: PMC9747819  PMID: 36352194

Correction to: Cellular Oncology

https://doi.org/10.1007/s13402-022-00713-5

In this article an incorrect affiliation had inadvertently been added. The original article has been updated.

Footnotes

Publisher's note

Springer Nature remains neutral with regard to jurisdictional claims in published maps and institutional affiliations.

Contributor Information

Michela Pasello, Email: michela.pasello@ior.it.

Katia Scotlandi, Email: katia.scotlandi@ior.it.

Articles from Cellular Oncology (Dordrecht) are provided here courtesy of Springer

RESOURCES